[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353940-105":59,"doc-detail-353940-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cervical-cancer-screen-and-treat-services-at-hiv-treatment-sites-in-nigeria-findings-from-the-icon-3-practice-based-research-network","Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria - findings from the ICON-3 Practice Based Research Network","","Cervical cancer remains a major public health concern in Nigeria, especially among women living with HIV (WLHIV), for whom early detection and treatment are critical yet screening and care access remain limited. The ICON-3 Practice Based Research Network ACCESS Study evaluates implementation strategies in 12 Nigeria Implementation Science Alliance Model Innovation and Research Centers (NISA-MIRCs). A baseline cross-sectional assessment measured screening, pre-cancer treatment, and referral using electronic medical records and descriptive statistics. Results summarize coverage gaps and regional disparities, including screening uptake, on-site treatment after VIA positivity, and referral patterns for suspected cancer cases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cervical-cancer-screen-and-treat-services-at-hiv-treatment-sites-in-nigeria-findings-from-the-icon-3-practice-based-research-network/353940/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cervical-cancer-screen-and-treat-services-at-hiv-treatment-sites-in-nigeria-findings-from-the-icon-3-practice-based-research-network/353940.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why focus on cervical cancer screening and treatment at HIV treatment sites in Nigeria?","Question",{"text":112,"@type":113},"Cervical cancer is preventable and treatable, but many women living with HIV do not access screening and treatment services, creating a major public health gap in Nigeria.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were baseline screening and referral outcomes assessed before the trial?",{"text":117,"@type":113},"A baseline cross-sectional study used electronic medical records to evaluate cervical cancer screening, pre-cancer treatment, and referral for suspected cancer at 12 NISA-MIRCs.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about screening uptake and treatment after VIA positivity?",{"text":121,"@type":113},"Among 23,409 WLHIV visiting the sites over six months, 57.7% were eligible for screening but only 33.3% were screened; among those testing positive on VIA, 73.2% were treated on-site.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353940,1790264055,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Chigbu etal. BMC Health Services Research (2026) 26:412 BMC Health Services Research  \n[https://doi.org/10.1186/s12913-026-14167-0](https://doi.org/10.1186/s12913-026-14167-0)  \nRESEARCH Open Access  \nCervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network  \nChibuike O. Chigbu 1,2, Cyril C. Dim 1,2, Stanley C. Eneh 1, Babayemi O. Olakunde 1,3, John O. Olawepo 1,4, Tonia C. Onyeka 1,5, Ijeoma U. Itanyi 1,6,7, Ngozi Idemili-Aronu 1,8, Nwamaka N. Lasebikan 1,9, Chinenye Bembir1, Esther Audu10, Omeje Ejiofor11, Nicholas Hamman12, Sagir Muhammad13, Atakulu Lawrence 14, Odufunke Maijeh15, Onyeji John16, Idayat Yinusa 17, Bala Barka 12, Aisha Abdulrahmeen18, Ezechukwu Paschalina 19, Obuchuku Nwafor20, Gregory A. Aarons21,22,23 and Echezona E. Ezeanolue 1,24*  \nAbstract  \nBackground Cervical cancer remains a major public health concern in Nigeria, particularly among women living with HIV (WLHIV) . While treatable if detected early, many WLHIV do not access cervical cancer screening and treatment services. Accordingly, the Accelerating Cervical Cancer Elimination through the integration of Screenand-treat Services (ACCESS) Study aims to test implementation strategies to enhance cervical cancer screening and treatment among WLHIV in 12 Nigeria Implementation Science Alliance Model Innovation and Research Centers (NISA-MIRCs) of the ICON-3 Practice Based Research Network.  \nMethods Prior to the trial commencement, we conducted a baseline cross-sectional study to assess cervical cancer screening, pre-cancer treatment, and referral for suspected cancer treatment at the 12 NISA-MIRCs. Data were obtained from electronic medical records and analyzed with descriptive statistics.  \nResults Out of 23,409 WLHIV who visited the sites during a six-month period (March to August 2023), 13,518 (57 . 7%) were eligible for screening, but only 4,499 (33 . 3%) were screened. The South West had the highest screening rate (65 . 5%), while the North West had the lowest (22 .4%) . Of the 112 WLHIV (2 . 7%) who screened positive with visual inspection with acetic acid (VIA), 73 . 2% were treated on-site. Twenty-three (0 . 5%) of those screened had suspected cancer, out of which 15 (65 . 2%) were referred to an oncology center.  \nConclusions The results show significant gaps in cervical cancer prevention services in Nigeria and considerable regional disparities. There is a need for implementation research studies, such as ACCESS, to identify effective strategies for improved cervical cancer screening and treatment among WLHIV in Nigeria.  \n*Correspondence: Echezona E. Ezeanolue [admin@ivaninstitute.org](admin@ivaninstitute.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nChigbu et al. BMC Health Services Research (2026) 26:412 Pag","cbCaio3rqvAcADuo","https://ap.wps.com/l/cbCaio3rqvAcADuo","pdf",730954,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why focus on cervical cancer screening and treatment at HIV treatment sites in Nigeria?\",\"answer\":\"Cervical cancer is preventable and treatable, but many women living with HIV do not access screening and treatment services, creating a major public health gap in Nigeria.\"},{\"question\":\"How were baseline screening and referral outcomes assessed before the trial?\",\"answer\":\"A baseline cross-sectional study used electronic medical records to evaluate cervical cancer screening, pre-cancer treatment, and referral for suspected cancer at 12 NISA-MIRCs.\"},{\"question\":\"What did the results show about screening uptake and treatment after VIA positivity?\",\"answer\":\"Among 23,409 WLHIV visiting the sites over six months, 57.7% were eligible for screening but only 33.3% were screened; among those testing positive on VIA, 73.2% were treated on-site.\"}]","Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria - findings from the ICON-3 Practice Based Research Network | PDF",1790108070,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89f3482683b30829b479ef7606668947.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9eea673a683761fe19441900a3bfc129.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9c7837d5ee6fb2a45aef8535fb8d0f9.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b35c6747f95232803ced50278103fb58.webp",980,1306]